National Center for Advancing Translational Sciences |

U.S. Department of Health & Human Services Divider arrow

National Institutes of Health Alt desc

Skip Over Navigation Links

NCATS Releases Bold Strategic Plan

NCATS’ new Strategic Plan highlights four major themes: translational science, collaboration and partnerships, education and training, and stewardship.

klebsiella pneumoniae interacting with a human white blood cell

NIH Team Identifies Potential Therapies for Drug-Resistant Bacteria

NCATS helps discover a new way to identify drugs to fight antibiotic-resistant bacteria that are a source of fatal infections, including in hospitals nationwide.

Mature cardiac cells properly aligned and functional on the heart chip.

Next Phase of Tissue Chip for Drug Screening Program

NCATS announced a funding opportunity to create disease models using tissue chip technology to test the effectiveness of candidate drugs for clinical trials.

NCATS to Support Tissue Chip for Drug Screening Testing Centers

NCATS announced approximately $6 million in new awards to establish testing centers that will enable scientists to test and validate tissue chip platforms independently.

November E-Newsletter Now Available

Read about NCATS’ new Strategic Plan, a CTSA Program-supported scientist awarded a 2016 MacArthur Foundation “genius grant,” research to combat antibiotic resistance and more.

Previous Pause Next

NCATS Releases Bold Strategic Plan

NCATS’ new Strategic Plan highlights four major themes: translational science, collaboration and partnerships, education and training, and stewardship.

More...

November E-Newsletter Now Available

Read about NCATS’ new Strategic Plan, a CTSA Program-supported scientist awarded a 2016 MacArthur Foundation “genius grant,” research to combat antibiotic resistance and more.

More...

NIH Team Identifies Potential Therapies for Drug-Resistant Bacteria

NCATS helps discover a new way to identify drugs to fight antibiotic-resistant bacteria that are a source of fatal infections, including in hospitals nationwide.

More...

Next Phase of Tissue Chip for Drug Screening Program

NCATS announced a funding opportunity to create disease models using tissue chip technology to test the effectiveness of candidate drugs for clinical trials.

More...

NCATS to Support Tissue Chip for Drug Screening Testing Centers

NCATS announced approximately $6 million in new awards to establish testing centers that will enable scientists to test and validate tissue chip platforms independently.

More...

Previous Pause Next

More Center News

Illuminating the Druggable Genome (IDG) Studying Human Proteins
Learn about the Illuminating the Druggable Genome program's new funding opportunities.

Team of doctors discussing how research advances can help treat epilepsy. Feasibility Assessment Funded
Collaboration to develop Biomedical Data Translator that will integrate existing data.

Director's Corner

Christopher P. Austin, M.D.

NEW Director's Message
NEW NCATS Strategic Plan
NEW NCATS E‑Newsletter
NCATS Annual Report (PDF - 3MB)
Director's Biography
Election to National Academy of Medicine

View Rare Disease Patient Videos

Watch rare disease patients and caregivers talk about the challenges they face and how NIH’s collaborative research efforts offer hope. View the videos.

Work with Us

Learn more about all the ways that potential grantees, partners and collaborators can access NCATS support to advance translational science.

NCATS Programs & Initiatives
NCATS encourages partnerships that cross many scientific disciplines and research sectors in pursuit of translational success.
Small Business Opportunities
NCATS’ small business programs help entrepreneurs develop and commercialize new translational technologies.
Expertise & Resources
NCATS staff are experts in translation, and the Center’s resources support pre-clinical and clinical activities.
Licensing Opportunities
NCATS makes it easy for industry and academia to interact and partner with Center laboratories and scientists.